Skip to main content

FGFR3 Antibody - BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-41227

Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Validated:

Human, Mouse, Rat

Predicted:

Chicken (95%). Backed by our 100% Guarantee.

Applications

Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, ELISA, Immunocytochemistry/ Immunofluorescence

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Format

BSA Free

Concentration

1 mg/ml

Product Specifications

Immunogen

Antibody was raised against a 19 amino acid peptide near the carboxy terminus of human FGFR3. The immunogen is located within amino acids 630 - 680 of FGFR3. Amino Acid Squence: RDVHNLDYYKKTTNGRLPV

Specificity

At least three isoforms of FGFR3 are known to exist; this antibody will detect all three.

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Theoretical MW

92, 98 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Description

Novus Biologicals Rabbit FGFR3 Antibody - BSA Free (NBP2-41227) is a polyclonal antibody validated for use in IHC, WB, ELISA and ICC/IF. All Novus Biologicals antibodies are covered by our 100% guarantee.

Scientific Data Images for FGFR3 Antibody - BSA Free

Western Blot: FGFR3 AntibodyBSA Free [NBP2-41227]

Western Blot: FGFR3 AntibodyBSA Free [NBP2-41227]

Western Blot: FGFR3 Antibody [NBP2-41227] - SK-N-SH cell lysate with FGFR3 antibody at (A) 0.5 and (B) 1 ug/mL.
FGFR3 Antibody - BSA Free

Immunocytochemistry/ Immunofluorescence: FGFR3 Antibody - BSA Free [NBP2-41227] -

Immunocytochemistry/ Immunofluorescence: FGFR3 Antibody - BSA Free [NBP2-41227] - Immunofluorescence of FGFR3 in rat brain tissue with FGFR3 antibody at 20 u/mL.
FGFR3 Antibody - BSA Free

Immunohistochemistry: FGFR3 Antibody - BSA Free [NBP2-41227] -

Immunohistochemistry: FGFR3 Antibody - BSA Free [NBP2-41227] - Immunohistochemistry of FGFR3 in rat brain tissue with FGFR3 antibody at 2.5 ug/mL.

Applications for FGFR3 Antibody - BSA Free

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

20 ug/ml

Western Blot

1 - 2 ug/mL

Formulation, Preparation, and Storage

Purification

Peptide affinity purified

Formulation

PBS

Format

BSA Free

Preservative

0.02% Sodium Azide

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C.

Background: FGFR3

FGFR3 (fibroblast growth factor receptor 3), also known as CEK2 and CD333, is a transmembrane receptor tyrosine kinase that plays a role in skeletal development and tumorigenesis. Alternative splicing generates beta isoforms of the receptor which lack the first Ig-like domain as well as IIIb isoforms that have a substitution in the third Ig-like domain. FGFR3 (IIIb) triggers cell proliferation in response to FGF acidic and FGF-9, while FGFR3 (IIIc) shows a wider selectivity that includes FGF acidic, FGF basic/FGF2, FGF-4, -8, -9, -17, -18, -19, and -20. FGF mediated activation of FGFR3 is dependent on the presence of heparan sulfate proteoglycans. FGFR3 functions as a negative regulator of endochondral bone growth, and FGFR3 mutations are associated with chondrodysplasia in humans. The development of many cancers is associated with mutations or dysregulation of FGFR3.

Long Name

Fibroblast Growth Factor Receptor 3

Alternate Names

CD333, CEK, FGF R3, JTK4

Gene Symbol

FGFR3

Additional FGFR3 Products

Product Documents for FGFR3 Antibody - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for FGFR3 Antibody - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...